Real-World Decisions: Implementing Disease-Modifying Obesity Therapy in Primary Care
-
11m 35s
-
11m 26s
-
9m 28s
Part of New Horizons in Obesity Management, this expert-led, primary care-focused symposium features three case-based discussions delivering practical strategies for GLP-1 receptor agonists, dual incretins and lifestyle integration, translating clinical trial data into everyday clinical practice.
Chaired by Prof Richard Hobbs (University of Oxford, Oxford, UK), the global faculty panel includes Dr Sean Wharton (Wharton Medical Clinic, Ontario, Canada), Dr Lydia Alexander (Enara Health, San Mateo, USA), and Dr Helen Parretti (Beccles Medical Centre, Beccles, UK). The faculty address treatment initiation and referral timing, cost considerations and specialist coordination, helping clinicians build confidence in early intervention, patient motivation and multidisciplinary care to transform front-line CKM management.
Following each case presentation, the faculty discuss patient presentation, navigating competing priorities, practical treatment initiation, alignment with evolving guidelines, escalation strategies, framing obesity as a chronic disease, and reinforcing sustainable behaviour change. The panel also addresses audience questions and conclude with a practical takeaway - one thing they would do tomorrow in clinical practice.
Access the full session on demand to stay at the forefront of obesity and CKM care.
Key Learning Objectives
- Recognise obesity as a chronic disease and discuss its role in CKM diseases
- Interpret current evidence for pharmacologic therapies
- Discuss effective communication strategies to engage patients in discussion about weight
- Apply evidence-based approaches to starting on or referring patients for obesity therapies in primary care settings
- Integrate obesity care into MDT CKM pathways
Target Audience
- Primary Care Physicians
More from this programme
Part 1
Case 1: Obesity with Diabetes and Emerging CKM Risk
Dr Sean Wharton introduces the first case, followed by a panel discussion on management strategies and how to navigate competing priorities in a 10-minute consultation.
Part 2
Case 2: Obesity Without Diabetes but High CV Risk
Dr Lydia Alexander presents the second case, followed by a panel discussion on evolving guidelines and conversations around patient expectations.
Part 3
Case 3: Post Initiation, Monitoring, Response and Escalation
Dr Helen Parretti presents the final case, followed by a panel discussion on personalised patient choices and patient priorities.
Part 4
Audience Questions and Panel Discussion
The symposium concludes with an engaging panel discussion and a live Q&A with the audience, chaired by Prof Richard Hobbs, followed by a 30-second reflection from each faculty member on what they would change in their clinical practice tomorrow.
Faculty Biographies
Helen Parretti
Dr Helen Parretti is a GP at the Beccles Medical Centre in Suffolk, UK. Dr Parretti is a clinical academic and researcher with an interdisciplinary background spanning chemistry and medicine. She holds an MA in Chemistry from the University of Oxford, a PhD in Solid State Chemistry from the University of Birmingham, and an MBBS from St George’s, University of London, alongside an MSc with Distinction in Clinical Primary and Community Care.
Her research interests are in obesity and primary care. Her research is focussed on improving the care of people living with obesity, in particular within primary care settings, with particular expertise in the long term care of patients who have had bariatric surgery. In addition to conducting clinical trials, Helen has completed several qualitative studies, systematic reviews and studies using routine GP data.